Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07806565
PHASE2/PHASE3

Naloxone for In-Hospital Cardiac Arrest

Sponsor: Region Skane

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to learn if the drug naloxone in addition to cardiopulmonary resuscitation improves outcomes of in-hospital cardiac arrets. The main questions it aims to answer are: Does naloxone improve survival after the cardiac arrest? Does naloxone improve functional outcome in survivors of cardiac arrest? Does naloxone improve health related quality of life after the cardiac arrest? How common are adverse reactions to naloxone when administered during cardiopulmonary resuscitation. Researchers will compare naloxone to a placebo (a look-alike substance that contains no drug) to see if naloxone works during cardiac arrest.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

850

Start Date

2027-01-01

Completion Date

2031-07-01

Last Updated

2026-09-08

Healthy Volunteers

No

Conditions

Interventions

DRUG

naloxone

2 mg naloxone administered intravenously or intraosseously

DRUG

Placebo

0.9% saline administered intravenously or intraosseously